Navigation Links
UC Regents Approve Fundraised Campaign for UCSF Medical Center at Mission Bay

The University of California Board of Regents today approved a proposed campaign to raise at least $500 million toward the development of the first phase of UCSF Medical Center at Mission Bay.

UCSF is planning to build a 289-bed, integrated medical center to serve children, women and cancer patients on a 14.5-acre parcel, which is south of UCSFs existing 43-acre life sciences campus at Mission Bay. Upon completion of the first phase in 2014, the 865,000-plus-gross-square-foot hospital complex will include:

A 183-bed childrens hospital and pediatric primary and specialty ambulatory care facilities

A 36-bed womens hospital and limited womens ambulatory services

A 70-bed cancer hospital

A central utility plant, underground tunnel, bridge, helipad and parking

The UCSF Medical Center at Mission Bay will provide a world-class, sophisticated, efficient, flexible and family-centered healing environment. The technologically advanced facilities will provide comprehensive diagnostic, interventional and support services, and use advanced robotic and imaging technology during surgery.

Its a momentous time for UCSF, said Mark Laret, chief executive officer of UCSF Medical Center. We are embarking on a bold plan to build a state-of-the-art hospital complex at Mission Bay. By locating the medical center at Mission Bay, with its fertile research environment, UCSF will be able to bring together the best scientists and clinicians to accelerate the pace of discovery into new medical advances that directly benefit patients.

The first phase of the Mission Bay hospital project is estimated to cost about $1.3 billion. State support for these facilities is expected to be limited; therefore, any new hospital construction must be financed through a combination of medical center reserves, debt financing and private support.

The campus has received significant early ind ication of private support for the project. The fundraising campaign is being conducted jointly by the University and UCSF Foundation, under the leadership of Senior Vice Chancellor Bruce Spaulding and Associate Vice Chancellor James Asp.

The plan to build new facilities at Mission Bay allows UCSF to increase inpatient and outpatient capacity to meet growing patient demand, address old and outdated facilities, and comply with state-mandated earthquake safety standards for hospitals. The new medical center is a key element of UCSFs long-term vision to advance its education, research and patient care missions.


'"/>




Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. New FDA Approved Drug To Treat Migraine
3. New FDA Approved Drug NATRECOR For Heart Failure Patients
4. FDA Approves Contraceptive Ring
5. FDA Approves New HIV Drug, Viread
6. FDA Approves Birth Control Skin Patch
7. FDA Approves New Arthritis Drug, Bextra
8. FDA Approves Elidel Cream for Eczema
9. FDA Approves New Anti-Clotting Drug
10. FDA Approves New surgery Treatment for Farsightedness
11. FDA Approves Anti-Cancer Cell Drug - Zevalin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth has organized ... protect parental rights and civil liberties, and to restore transparency within government agencies ... coincides with a press conference taking place Friday morning calling on President Trump ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... and services, is proud to announce it has joined the National Association for ... the interests of chronically ill, disabled, and dying Americans of all ages and ...
(Date:3/28/2017)... ... 2017 , ... Z-Medica, LLC, a leading developer and marketer ... will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 schools ... by the American College of Surgeons, U.S. Department of Defense, Department of Homeland ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... instruments are critical to ensuring high-quality results and maintaining GMP and USP compliance. ... Laboratory Instruments in accordance with GMP requirements " these requirements are explained. ...
(Date:3/28/2017)... ... 2017 , ... With less than 10,000 dermatologists in the United States and ... limited while the desire to conquer breakouts and eliminate skincare stress is widespread. ... online, today released its inaugural survey on the State of Acne in America. ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
Breaking Medicine Technology: